+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Congestive Heart Failure Treatment Device Market - Global Forecast 2026-2032- Product Image
Congestive Heart Failure Treatment Device Market - Global Forecast 2026-2032- Product Image
Sale

Congestive Heart Failure Treatment Device Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995113
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Congestive Heart Failure Treatment Device Market is projected to reach USD 24.30 Billion in 2026. It is expected to continue growing at a CAGR of 16.29%, reaching USD 60.35 Billion by 2032.

Congestive heart failure (CHF) treatment devices are becoming central to cardiovascular care as aging populations, hypertension, diabetes, ischemic heart disease, chronic kidney disease, and improved survival after cardiac events expand the heart failure burden. The device landscape spans cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), ventricular assist devices (VADs), implantable and wearable hemodynamic monitoring systems, ultrafiltration technologies, remote patient monitoring platforms, and connected post-discharge management tools.

Demand is supported by guideline-directed care, rising hospitalization costs, and payer interest in reducing preventable readmissions. The World Health Organization identifies cardiovascular disease as the leading global cause of death, while U.S. public health data show heart failure affects millions of adults and drives substantial medical spending, making CHF treatment devices a high-priority category for hospitals, payers, medtech manufacturers, and digital health innovators.

Transformative Shifts in CHF Device Care

The CHF treatment device landscape is shifting from episodic intervention toward continuous, data-enabled disease management. Hospitals increasingly evaluate devices not only by procedural performance but also by their ability to support longitudinal monitoring, medication optimization, fewer decompensation events, earlier escalation of care, and improved quality of life.

Transformative forces include miniaturized implantables, remote pulmonary artery and pressure monitoring, rechargeable and longer-life batteries, less invasive VAD implantation pathways, home-based monitoring, and value-based reimbursement. Regulatory pathways are also emphasizing real-world evidence, cybersecurity, interoperability, human factors, and post-market surveillance, raising the competitive importance of clinically validated outcomes.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the move from reactive CHF treatment to predictive care. AI-enabled analytics can combine device telemetry, weight, blood pressure, rhythm data, activity trends, laboratory values, medication history, and electronic health record signals to identify deterioration risk before symptoms trigger an emergency visit.

Its cumulative impact is strongest where algorithms are embedded into clinician workflows rather than deployed as standalone dashboards. Validated AI can improve triage, reduce alert fatigue, personalize device programming, support advanced therapy selection, improve remote cardiac care, and strengthen population-level risk stratification, while requiring transparent validation, bias monitoring, explainability, cybersecurity safeguards, and compliance with medical device software regulations.

Key Regional Insights for CHF Treatment Devices

North America remains a leading region for CHF treatment devices due to high diagnosed heart failure prevalence, advanced electrophysiology and heart failure programs, Medicare coverage pathways, specialist access, and early adoption of implantable monitoring and mechanical circulatory support. Europe benefits from established cardiac device reimbursement, strong clinical research networks, and European Union regulatory harmonization, although cost-containment pressures, health technology assessment requirements, and procurement scrutiny shape adoption across hospitals.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in cardiac care capacity, local manufacturing, tertiary hospitals, and connected health infrastructure. Latin America shows rising demand in Brazil and Mexico, supported by private hospital networks, urban specialty care, and increasing cardiovascular risk from hypertension, diabetes, and obesity. The Middle East is investing in tertiary cardiac centers, digital health programs, and high-acuity specialty care, while Africa’s opportunity is tied to access expansion, workforce training, affordable diagnostics, and scalable remote monitoring solutions for under-resourced cardiac systems.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Across ASEAN, CHF device adoption is supported by expanding private healthcare, medical tourism hubs, urban cardiology centers, and government efforts to strengthen chronic disease management, although reimbursement variability and uneven specialist distribution limit uniform uptake. The GCC is investing in specialty cardiac centers, national digital health systems, and advanced hospital infrastructure, making remote monitoring, premium implantables, and high-acuity heart failure pathways relevant to regional care delivery.

The European Union provides scale through shared regulatory frameworks, strong evidence standards, and coordinated health technology assessment priorities, while BRICS countries combine large patient populations with increasing domestic medtech capacity and demand for cost-effective cardiac devices. G7 markets lead in advanced implants, VAD programs, remote monitoring integration, and evidence generation. NATO economies, many overlapping with G7 and EU members, benefit from resilient procurement systems, cybersecurity priorities, interoperable digital infrastructure, and established cardiovascular care networks for connected cardiac devices.

Key Country Insights for CHF Treatment Device Adoption

The United States is the largest innovation and reimbursement anchor, with strong uptake of ICDs, CRT, remote monitoring, and VADs supported by advanced heart failure centers and public-private payer coverage. Canada emphasizes evidence-based access and provincial reimbursement, while Mexico and Brazil are important Latin American growth markets with expanding private cardiovascular care and increasing chronic disease burden. The United Kingdom, Germany, France, Italy, and Spain sustain demand through advanced cardiac centers, national guideline alignment, and established electrophysiology services, though budget scrutiny and technology assessment processes affect purchasing cycles.

Russia remains a specialized device market influenced by localization policies and access constraints. China is scaling domestic production, tertiary cardiac care, and digital hospital infrastructure, while India is driven by high disease burden, affordability needs, and the expansion of cardiac specialty hospitals. Japan emphasizes advanced aging-related care and sophisticated implantable device management, Australia supports structured cardiac services through specialist networks, and South Korea combines digital health capability, strong hospital infrastructure, and advanced cardiovascular care adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated differentiation, particularly devices that reduce heart failure hospitalization, support remote management, improve functional status, and integrate with guideline-directed medical therapy. Evidence strategies should include real-world outcomes, health economic endpoints, subgroup performance, durability data, safety surveillance, and usability findings for clinicians, caregivers, and patients.

Manufacturers should build interoperable platforms, strengthen cybersecurity, localize pricing for emerging markets, and partner with hospitals on service models that support implantation, monitoring, follow-up, and patient adherence. Commercial teams should align messaging to payers, electrophysiologists, heart failure specialists, cardiac surgeons, procurement leaders, and home-care providers, emphasizing total cost of care, workflow fit, fewer avoidable admissions, and measurable patient outcomes.

Research Methodology

This executive summary is based on secondary research from public health agencies, peer-reviewed cardiovascular literature, clinical practice guidelines, regulatory frameworks, reimbursement references, hospital technology assessment materials, and medtech industry reporting. Sources include established organizations such as WHO, CDC, AHA/ACC/HFSA, ESC, FDA, EMA, and national health authorities where applicable.

The analysis applies triangulation across disease burden, procedure trends, technology adoption, reimbursement environment, regulatory direction, clinical utility, and regional healthcare infrastructure. Insights are validated through consistency checks across epidemiology, guideline recommendations, safety evidence, post-market requirements, and procurement behavior to support reliable focused market interpretation without relying on market sizing, market share, or forecasting.

Conclusion

The CHF treatment device market is moving toward integrated, intelligence-enabled cardiac care that connects implants, monitoring, analytics, and clinical workflows. Adoption will be shaped by the ability to demonstrate fewer hospitalizations, better functional status, safer long-term support, durable device performance, and sustainable economics.

Organizations that combine robust evidence, interoperable design, AI-enabled risk detection, cybersecurity readiness, and regionally adapted access models are best positioned to address demand. As heart failure remains a major global health challenge, treatment devices will play an increasingly important role in precision cardiovascular management and long-term patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Congestive Heart Failure Treatment Device Market, by Device Type
7.1. Introduction
7.2. Cardiac Resynchronization Therapy Device
7.3. Implantable Cardioverter Defibrillator
7.4. Ventricular Assist Device
7.4.1. Biventricular Assist Device
7.4.2. Left Ventricular Assist Device
7.4.3. Right Ventricular Assist Device
8. Congestive Heart Failure Treatment Device Market, by Therapeutic Modality
8.1. Introduction
8.2. Electrical Stimulation
8.2.1. Asynchronous Pacemakers
8.2.2. Synchronous Pacemakers
8.3. Mechanical Circulatory Support
9. Congestive Heart Failure Treatment Device Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Specialty Clinics
10. Congestive Heart Failure Treatment Device Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributors
10.4. Online Sales
11. Congestive Heart Failure Treatment Device Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Congestive Heart Failure Treatment Device Market, by Group
12.1. NATO
12.2. G7
12.3. BRICS
12.4. European Union
12.5. ASEAN
12.6. GCC
13. Congestive Heart Failure Treatment Device Market, by Country
13.1. China
13.2. United States
13.3. Japan
13.4. India
13.5. Germany
13.6. United Kingdom
13.7. Australia
13.8. France
13.9. South Korea
13.10. Italy
13.11. Canada
13.12. Russia
13.13. Brazil
13.14. Mexico
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Abiomed, Inc.
15.3. Ancora Heart, Inc.
15.4. Berlin Heart GmbH
15.5. Biotronik SE & Co. KG
15.6. Boston Scientific Corporation
15.7. CardiacAssist, Inc.
15.8. Cook Medical LLC
15.9. CorWave SA
15.10. CVRx, Inc.
15.11. Edwards Lifesciences Corporation
15.12. Getinge AB
15.13. Jarvik Heart Inc.
15.14. Lepu Medical Technology Co., Ltd.
15.15. LivaNova PLC
15.16. MEDICO S.p.A.
15.17. Medtronic plc
15.18. MicroPort Scientific Corporation
15.19. OSCOR Inc.
15.20. Osypka Medical GmbH
15.21. Otsuka Pharmaceutical Co., Ltd.
15.22. ReliantHeart, Inc.
15.23. Shree Pacetronix Ltd.
15.24. SynCardia Systems LLC
15.25. Terumo Corporation
15.26. Vitatron B.V.
15.27. W. L. Gore & Associates, Inc.
15.28. Zoll Medical Corporation
List of Figures
FIGURE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 58. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 59. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 60. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 61. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 62. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 63. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 65. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 66. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 67. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 68. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 69. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 70. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 72. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 73. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 74. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 75. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 76. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 77. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 79. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 80. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 81. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 82. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 83. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 84. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 86. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 87. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 88. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 89. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 90. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 91. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 93. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 94. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 95. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 96. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 97. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 101. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 102. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 103. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 104. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 105. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 106. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 108. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 109. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 110. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 111. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 112. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 113. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 115. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 116. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 117. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 118. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 129. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 130. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 131. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 132. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 134. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 136. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 137. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 138. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 139. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 143. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 144. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 145. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 146. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 147. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 148. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 149. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 150. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 151. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 152. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 153. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 154. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 155. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 156. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 157. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 158. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 159. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 160. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 161. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 163. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 164. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 165. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 166. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 167. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 168. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 169. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 170. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 171. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 172. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 173. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 174. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 175. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 177. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 178. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 179. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 180. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 181. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 184. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 185. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 186. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 187. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 188. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 189. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 192. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 193. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 194. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 195. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 196. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 198. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 199. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 200. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 201. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 202. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 203. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 206. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 207. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 208. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 209. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 210. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 212. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 213. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 214. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 215. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 216. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 217. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 219. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 220. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 221. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 222. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 223. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 224. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 226. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 227. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 228. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 229. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 230. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 231. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 233. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 234. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 235. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 236. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 237. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 238. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 240. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 241. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 242. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2017-2032 (USD MILLION)
TABLE 243. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2017-2032 (USD MILLION)
TABLE 244. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2017-2032 (USD MILLION)
TABLE 245. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 248. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Abiomed, Inc.
  • Ancora Heart, Inc.
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardiacAssist, Inc.
  • Cook Medical LLC
  • CorWave SA
  • CVRx, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Jarvik Heart Inc.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • MEDICO S.p.A.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • OSCOR Inc.
  • Osypka Medical GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • ReliantHeart, Inc.
  • Shree Pacetronix Ltd.
  • SynCardia Systems LLC
  • Terumo Corporation
  • Vitatron B.V.
  • W. L. Gore & Associates, Inc.
  • Zoll Medical Corporation

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 24.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 60.35 Billion
Compound Annual Growth Rate16.2%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Congestive Heart Failure (CHF) Treatment Devices - Global Strategic Business Report - Product Image

Congestive Heart Failure (CHF) Treatment Devices - Global Strategic Business Report

  • Report
  • 177 Pages
  • Global
From
Congestive Heart Failure Treatment Devices Market Report 2026 - Product Image

Congestive Heart Failure Treatment Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Congestive Heart Failure (CHF) Treatment Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Congestive Heart Failure (CHF) Treatment Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 132 Pages
  • Global
From
Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2026-2034 - Product Image

Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2026-2034

  • Report
  • 139 Pages
  • Global
From
Cardiac Pacemaker Market by Type, Technology, Indication, End User, and Region 2026-2034 - Product Image

Cardiac Pacemaker Market by Type, Technology, Indication, End User, and Region 2026-2034

  • Report
  • 139 Pages
  • Global
From

About the Congestive Heart Failure Device Market

The Congestive Heart Failure Device market is a subset of the Cardiovascular Devices market. It includes a range of devices used to treat congestive heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These devices include implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and left ventricular assist devices (LVADs). These devices are designed to improve the quality of life of patients with congestive heart failure by providing support to the heart and helping to regulate its rhythm. Some of the major companies in the Congestive Heart Failure Device market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and LivaNova. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.